VHL and neoplasm: Considering the evolution of the patient and the differences with respect to first-degree relatives (bearing a VHL mutation but lacking the CHECK2 mutation), is very likely that the combination of mutations in two different tumour suppressor genes is responsible for the more aggressive behaviour of the disease in patient III-1.